About NSGC

2018 Premier Sponsors

NSGC gratefully acknowledges our Premier Sponsors who support NSGC throughout the year, making many NSGC Programs possible. These programs provide valuable education to genetic counselors and foster research for the betterment of our profession. We thank the following Premier Sponsors for their generous support.


Platinum Level

Since 1999, our mission has remained focused on understanding disease better so cures can come faster. Through our ongoing research, we give health care providers clearer information so they can accurately guide patient care. Visit www.ambrygen.com


AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three main therapy areas – Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit www.astrazeneca-us.com and follow us on Twitter @AstraZenecaUS.

Products and services:
LYNPARZA® (olaparib): A first-of-its-kind medication - with 3 distinct indications - that has treated nearly 5500 patients since launch in 2014.

Gold Level


Amicus Therapeutics is a global biotechnology company at the forefront of therapies for rare and orphan diseases. The Company has a robust pipeline of advanced therapies for a broad range of human genetic diseases.

Invitae Logo (002).png

Invitae's mission is to bring genetic information into mainstream medical practice to improve the quality of healthcare for billions of people across all stages of life. Visit www.invitae.com to learn more.

Featured products and services:

Invitae Carrier Screen: Three pre-curated panels, and a customizable test menu with options to screen for more than 287 genes.

Invitae Multi-Cancer Panel: Genetic testing for 83 genes associated with hereditary cancers across eight major organ systems: breast and gyn, gastrointestinal, endocrine, genitourinary, skin, brain/nervous system, sarcoma, and hematologic.

CancerGene Connect: A complimentary risk assessment and pedigree tool for all clinicians.

Silver Level

NTD_Eurofins Clinical Diagnostics.jpg

Eurofins NTD is a healthcare company committed to healthier pregnancies, babies and families. NTD and our partners provide a comprehensive portfolio of services ranging from biochemical screening for aneuploidy and risk of early onset preeclampsia, to non-invasive prenatal testing (NIPT), to genetic carrier screening.


Pfizer Oncology is committed to pursuing innovative treatments that are helping to redefine life with cancer. As an oncology leader with one of the most robust oncology pipelines in the industry, we are focused on translating scientific breakthroughs into clinical application. Additionally, we are dedicated to working collaboratively with the community to make a positive impact on people’s lives. Learn more about Pfizer Oncology here.


NSGC Executive Office   |   330 North Wabash Avenue, Suite 2000, Chicago, IL 60611   |   312.321.6834   |   nsgc@nsgc.org
© 2019 National Society of Genetic Counselors   |   Privacy Policy   |   Disclaimer   |   Terms and Conditions   |   DMCA Procedures for Removal